Due to these and numerous other beneficial effects on systems metabolism, pharmacological modulation of the endogenous ghrelin system is widely considered a promising approach to treat a variety of metabolic complications, most prominently gastroparesis and pathological underweight associated with anorexia nervosa or cancer cachexia. This evidence concerns the gene GHRL and anorexia nervosa.